Reckitt Benckiser Pharmaceuticals Inc. Announces FDA Approval of Two New Dosage Strengths of Suboxone(R) Sublingual Film (C-III) for Maintenance Treatment of Opioid Dependence

RICHMOND, Va., Aug. 20, 2012 (HSMN NewsFeed) — Reckitt Benckiser Pharmaceuticals Inc. today announced the U.S. Food and Drug Administration (FDA) approval of the 4 mg and 12 mg doses of Suboxone® (buprenorphine and naloxone) sublingual film. Suboxon… Biopharmaceuticals, FDAReckitt Benckiser, Suboxone, buprenorphine, naloxone (Source: HSMN NewsFeed)